Sign in →

Test Code FDIL Free Phenytoin (Free Dilantin)

Specimen and Container/Tube

Specimen Type: Serum

Preferred Specimen: Red Top

Other Acceptable specimens: N/A

Specimen Handling and Transport Instructions

UCMC Onsite Instructions: 

Collect specimen per standard collection procedure and send to laboratory immediately. 

 

UCMC Offsite and UC MedLab Outreach Instructions: 

  • Samples should be centrifuged within 2 hours of collection.
  • Centrifuge specimens at >2500 x g for 10 minutes at room temperature.
  • Aliquot sample into plastic transport tube containing a minimum of 0.2 mL of specimen.
  • Samples must be sent refrigerated at 2-8oC.

Rejection Criteria

  • Common specimen rejected situations include: incorrect specimen type, insufficient volume, missing or incomplete specimen identifiers, incorrect specimen transport, or specimens outside stability limits. 
  • Specimens that are clotted or grossly hemolyzed.
  • Specimens that were transported unspun/whole blood and draw time is greater than 6 hours.

Reference Values

Test

Age

Sex

Reference Range

Free Dilantin

All

All

1.0 - 2.0 μg/mL

NOTE: Therapeutic ranges are based on those determined in conjunction with the Univeristy of Chicago Medicine Department of Pharmaceutical Services. 

Critical Values

Analyte

Unit

Low

High

Age

N/A

N/A

N/A

N/A

N/A

CPT Codes

80186

LOINC Codes

3969-3

Volume

Preferred Volume: 0.5 mL

Minimum Volume: 0.2 mL

Specimen Stability

Storage Temperature

Stability

Room temperature

N/A

Refrigerated

1 month

Frozen

3 months

Collection Instructions

Collect specimen per standard laboratory collection procedures. 

 

Test Components

Free Phenytoin ( Free Dilantin)

Clinical Indications

May be useful in cases associated with alterations in the binding of phenytoin to albumin. Not recommended for routine assessment of phenytoin.

In the treatment of epilepsy, phenytoin is indicated for grand mal epilepsy, cortical focal seizures and temporal lobe epilepsy.

Methodology

Ultrafiltration and Enzyme-Multiplied Immunoassay Technique (EMIT), Roche Diagnostics

Additional Information

  • Results should always be assessed in conjunction with patient's medical history, clinical examination and other findings.
  • Phenytoin is one of the most widely prescribed anticonvulsants and is occasionally used as a myocardial antiarrythmic.
  • The total concentration of the drug in the blood consists of the protein-bound fraction and the free fraction, of which only the free drug is considered to be pharmacologically active. Due to the fact that phenytoin is highly bound to plasma proteins (89 - 95%) , any alteration in the protein binding of phenytoin due to uremia, hypoalbuminemia, ingestion of other drugs or age, can result in a significantly different clinical response to a total phenytoin concentration.
  • Alcohol, barbiturates, and carbamezapine induce oxidative enzymes, which result in increased metabolism of phenytoin thereby reducing serum concentrations of free phenytoin and reduced pharmacological effect.
  • Chloramphenicol, cimetidine, disulfiram, isoniazid and dicumerol compete with phenytoin metabolism thereby resulting in increased serum concentrations of free phenytoin and enhancement of the pharmacological effect.
  • Salicylate, valproic acid, phenylbutazone, sulfisoxazole and sulfonylureas compete with phenytoin for serum protein binding sites which results in decreased total phenytoin while free phenytoin remains the same.
  • Monitoring serum phenytoin concentrations, along with careful clinical assessment, is the most effective means of improving seizure control, reducing the risk of toxicity and minimizing the need for additional anticonvulsant medication for the following reasons:
    • Serum phenytoin concentrations correlate better with pharmacologic activity than does dosage because of individual differences in absorption, metabolism disease states, concomitant medication, and compliance. Serum concentration monitoring helps physicians individualize dosage regimens.
    • The hepatic enzyme system for metabolizing phenytoin can become saturated within the drug's therapeutic range. When this occurs, small dosage alterations can lead to unexpected drug accumulation and clinical toxicity.
    • Phenytoin is safe and effective only in a narrow range of serum concentrations.

 

Turnaround Time

Turnaround times are relative to the time the specimen is received in the test laboratory. 

 

STAT Turnaround Time: Not Available

Routine Turnaround Time: 4 hours

Testing Schedule: Monday, Wednesday & Friday ONLY

 

NOTE: For testing requests outside of the timeframe below, please page the Chemistry Director On Call at X1769

Last Review Date

1/26/2023